Compare Amcor PLC (AMCR) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amcor PLC vs Enveric Biosciences Inc — how do they compare? Amcor PLC trades at $46.25 (market cap $21.92B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Amcor PLC is far larger — about 3535.5× Enveric Biosciences Inc's market cap, and Amcor PLC pays a 5.49% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| AMCR | ENVB | |
|---|---|---|
Market Cap | $21.92B | $6.20M |
Sector | Basic Materials | Health |
52-Week High | $50.58 | $17.40 |
52-Week Low | $36.69 | $1.27 |
Enterprise Value | $37.03B | $1.30M |
Dividend Yield | 5.49% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amcor PLC
Amcor is a global plastics packaging behemoth, with global sales of USD 14.5 billion in fiscal 2022 following the acquisition of Bemis in 2019. Amcor's operations span over 40 countries globally and include significant emerging-market exposure equating to circa 20% of sales. Amcor's capabilities span flexible and rigid plastic packaging, which sell into defensive food, beverage, healthcare, household, and personal-care end markets.
Read more on AMCR →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
